Stock Update (NYSE:ACT): Actavis Will Appeal Injunction Requiring Continued Distribution of NAMENDA® IR

[PR Newswire] – DUBLIN, Dec. 15, 2014 /PRNewswire/ — Actavis plc (ACT) today confirmed that it is filing an emergency appeal to the U.S. Court of Appeals for the Second Circuit seeking to . . . → Read More: Stock Update (NYSE:ACT): Actavis Will Appeal Injunction Requiring Continued Distribution of NAMENDA® IR Similar Articles: Market Update (NYSE:ACT): Actavis Names Maria Teresa Hilado Chief Financial Officer Market Update (NYSE:ACT): Actavis to Acquire Durata Therapeutics, Inc. Company Update (NYSE:ACT): Actavis to Present at Morgan Stanley Global Healthcare Conference 2014
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.